Ebola Drugs a Low Priority for Pharmaceutical Companies

While the world experiences the deadliest Ebola outbreak ever, the disease remains one that has no drugs to treat it. The San Francisco Chronicle says drug makers have little incentive to spend time and money on a disease that predominantly affects people in impoverished countries. Health officials tell the Chronicle this outbreak could encourage pharmaceutical companies to speed up the development process or lead small groups in risky drug trials.

SOURCE: San Francisco Chronicle


Related Stories

Ebola Containment Efforts Thwarted by Lax Enforcement
blog comments powered by Disqus